Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sublingual Flumazenil in Primary Hypersomnia
NCT01183312Phase 2Completed
- Start
- Sep 2010
- Primary completion
- Jan 2012
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
A Phase 2 trial of flumazenil in Primary Hypersomnia, idiopathic hypersomnia (IH), narcolepsy type 2 (NT2). Started Sep 2010; status: completed.
02
Drugs
flumazenil
03
Conditions
Primary Hypersomniaidiopathic hypersomnia (IH)narcolepsy type 2 (NT2)
Beyond the preview
Go deeper on NCT01183312.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01183312.